Quantcast
Last updated on April 16, 2014 at 8:06 EDT

Latest American Association for Cancer Research Stories

2014-04-03 08:30:29

- Company to Present Data on SF3B1 Program at a Symposium During the American Association for Cancer Research Annual Meeting 2014 - CAMBRIDGE, Mass., April 3, 2014 /PRNewswire/ -- H3 Biomedicine Inc., a biopharmaceutical company specializing in the discovery and development of precision medicines for oncology, announced today that it has named its lead investigational drug candidate for its program that targets SF3B1, a component of the human genetic splicing machinery that has been...

2014-04-03 04:20:47

SAN DIEGO and HILDEN, Germany, April 3, 2014 /PRNewswire/ -- - New innovative product launches at American Association for Cancer Research (AACR) Annual Meeting add to broad portfolio of NGS solutions - High-speed QIAxpert accelerates quantification and quality control of nucleic acids with easy-to-use software and analysis aiding sample-to-insight workflows - CLC Cancer Research Workbench is the world's first...

2014-04-02 12:32:51

New data demonstrates VAL-083 has promise as a potential treatment of non-small cell lung cancer (NSCLC) and glioblastoma multiforme (GBM) VANCOUVER, British Columbia and MENLO PARK, Calif., April 2, 2014 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") today announced that the Company would present two abstracts at the 105th Annual Meeting of the American Association for Cancer Research (AACR), which is being held April 5-9, 2014, in San Diego. The Company...

2014-03-27 08:35:19

Robust antitumor activity of G1's novel CDK4/6 inhibitors to be highlighted in poster on April 7 CHAPEL HILL, N.C., March 27, 2014 /PRNewswire/ -- G1 Therapeutics, Inc., a privately held pharmaceutical company that focuses on the discovery and development of novel small molecules for use in cancer therapy and biodefense applications, today announced that it will reveal new data on its novel, potent and selective cyclin-dependent kinases 4 and 6 (CDK4/6) inhibitors during a poster...

2014-03-19 16:20:12

Hyundai Hope On Wheels will announce its 2014 Grants Program FOUNTAIN VALLEY, Calif., March 19, 2014 /PRNewswire/ -- Hyundai Hope On Wheels®, a leading contributor to pediatric cancer research nationwide, announced today it will sponsor the Pediatric Cancer Town Hall Meeting at the 105(th) Annual Meeting of the American Association for Cancer Research to be held April 5-9, 2014 in San Diego, Calif. http://photos.prnewswire.com/prnvar/20131002/LA90771LOGO-b The Pediatric Cancer...

2014-02-21 23:26:12

Dr. Harald Zur Hausen is Attending As Key Note Speaker of OMICS Group's 4th World Congress on Virology Henderson, Nevada (PRWEB) February 21, 2014 OMICS Group International’s Managing Director and CEO, Dr. Srinubabu Gedela and OMICS Group comrades met with Prof. Dr. Harald Zur Hausen at BioAsia 2014 conference in Hyderabad, India on 20th February 2014. The Group met with Dr. Hausen, who is a Nobel Laureate, to discuss the agenda of the 4th World Congress on Virology, a conference...

2014-01-29 08:27:03

First Joint Project Involves a $20 Million Dream Team Grant for Lung Cancer Research To Be Awarded in 2015 LOS ANGELES, Jan. 29, 2014 /PRNewswire/ -- The American Cancer Society, the largest voluntary health organization in the world dedicated to eliminating cancer, and Stand Up To Cancer (SU2C), the charitable initiative supporting groundbreaking research aimed at getting new treatments to patients in an accelerated time frame, announced today an historic collaboration in the...

2014-01-20 10:32:20

Men who walked at a fast pace prior to a prostate cancer diagnosis had more regularly shaped blood vessels in their prostate tumors compared with men who walked slowly, providing a potential explanation for why exercise is linked to improved outcomes for men with prostate cancer, according to results presented here at the AACR-Prostate Cancer Foundation Conference on Advances in Prostate Cancer Research, held Jan. 18-21. Men who engage in higher levels of physical activity have been...

Melatonin May Play A Role In Reducing Risk Of Prostate Cancer
2014-01-20 03:56:23

American Association for Cancer Research Higher levels of melatonin, a hormone involved in the sleep-wake cycle, may suggest decreased risk for developing advanced prostate cancer, according to results presented in San Diego at the AACR-Prostate Cancer Foundation Conference on Advances in Prostate Cancer Research, held Jan. 18-21. Melatonin is a hormone that is produced exclusively at night in the dark and is an important output of the circadian rhythm, or the body's inherent 24-hour...

2014-01-13 08:29:07

PHILADELPHIA, Jan. 13, 2014 /PRNewswire/ -- The American Association for Cancer Research (AACR) and Debbie's Dream Foundation: Curing Stomach Cancer (DDF) are pleased to announce a new fellowship opportunity in gastric cancer research. (Photo: http://photos.prnewswire.com/prnh/20140113/PH44438 ) The Debbie's Dream Foundation-AACR Gastric Cancer Fellowship represents a joint effort to encourage and support a postdoctoral or clinical research fellow to conduct gastric cancer research...